Efficacy and safety of adalimumab (ADA) in patients with nonradiographic axial spondyloarthritis (nr-axSpA): Open-label period results from the ABILITY-3 study

Authors
Category Primary study
ConferenceInternational Journal of Rheumatic Diseases
Year 2017
This article has no abstract
Epistemonikos ID: 545e61c547d662fb7c9e79121f3ea80c74970b0d
First added on: Apr 29, 2026